Drugs / C1 Inhibitor Concentrate
C1 Inhibitor Concentrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00119431 | Sep 2005 → Mar 2006 | hereditary angioedema type 1 | Prothya Biosolutions | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C1 Inhibitor Concentrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00119431 ↗ |
| Known as | C1-esteraseremmer-N | “nanofiltered Cetor® (called C1-esteraseremmer-N during the development phase)” NCT00119431 ↗ |
| Known as | Cetor | “nanofiltered Cetor® (called C1-esteraseremmer-N during the development phase)” NCT00119431 ↗ |